The way Neuroelectrics wants to treat depression and epilepsy without drugs
During the first day of the Valencia Digital Summit, which after last year was held in hybrid mode, an important part was dedicated to startups. Among the most interesting ones…
John McAfee, the crazy life of the father of antivirus
A visionary with a mania for money and beautiful girls, characterised by a hatred of the mundane office life, who turned all stereotypes on their head in the parable of…
Varda raises $90 million to fuel space manufacturing efforts
By Jaspreet Singh and Akash Sriram (Reuters) – Varda Space Industries, a startup that is developing technology to produce drugs autonomously in space, said on Friday it has raised $90…
Quantum Computing: what it is and why everyone is looking for it
Quantum computing, a revolutionary technology that harnesses the principles of quantum physics, is poised to perform calculations that are beyond the reach of classical computers. By processing information in parallel…
Lights and shadows of AI according to Hassabis, CEO of Google Deepmind
During the days of the Mobile World Congress in Barcelona, I had the opportunity to listen to Demis Hassabis, co-founder of DeepMind, one of the most well-known and influential companies focused on…
Gilead Sciences raises stake in cancer-centric Arcus Biosciences to 33%
By Pratik Jain (Reuters) – Gilead Sciences said on Monday it has raised its stake in Arcus Biosciences to 33% and expanded its presence in the drug developer’s board to…
AI defined 2023. Bullets and ballots will shape 2024
By Simon Robinson (Reuters) – How to sum up the most important news of the year past? The obvious answer in 2023 is to use Artificial Intelligence (AI). In that…
New developments in medicine: from paper waste to ibuprofen
When most people think of the pharmaceutical industry, there is often no association between producing life-saving drugs (ibuprofen) and environmental impact. But according to a 2019 study by The Conversation,…
AI startups bringing dollars but lean workforces to ailing San Francisco
By Anna Tong AI startups: SAN FRANCISCO (Reuters) – In a frenzy unseen since the birth of social media in the early 2000s, investors are pouring billions into generative AI and…
Neuralink and Synchron, two challenge to change patients’ lives with chips in the brain
Neuralink is ready to test brain implants on humans. The announcement came from the company in a surprise tweet following the Food and Drugs Administration‘s rejections of three previous applications. This time the…